Uncategorized
LUMINOUS study: Ranibizumab improves visual acuity in treatment naïve patients at 1 year
SEATTLE — Treatment naïve patients who were administered ranibizumab for neovascular age-related macular degeneration showed an improvement in visual acuity at 1 year, according to a poster presentation of the LUMINOUS study here. “The presenting visual acuity and number of injections given determines the visual outcome. The better the presenting visual acuity, the better the outcome,” Christopher Brand, MD, told Ocular Surgery News in an interview at the Association for Research in Vision and Ophthalmology meeting. “If you want a good outcome at 12 months, you need to treat your (Read more...)